pI: 6.0829 |
Length (AA): 918 |
MW (Da): 100360 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
39 | 691 | 4uqi (B) | 4 | 618 | 29.00 | 0 | 1 | 0.800855 | 0.66 |
120 | 220 | 4jw3 (C) | 15 | 103 | 33.00 | 0 | 0.98 | 0.350502 | -0.3 |
158 | 268 | 3woz (A) | 650 | 765 | 14.00 | 0 | 0.87 | 0.326383 | -0.81 |
740 | 918 | 3zgh (A) | 205 | 371 | 10.00 | 0 | 0.01 | 0.158377 | -0.04 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128048)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55480 | AP3-complex subunit beta-A |
Brugia malayi | Bm1_48425 | Adaptin N terminal region family protein |
Candida albicans | CaO19.8903 | similar to S. cerevisiae APL6 (YGR261C) beta-adaptin, large chain of the clathrin-associated protein AP-3 complex |
Candida albicans | CaO19.1323 | similar to S. cerevisiae APL6 (YGR261C) beta-adaptin, large chain of the clathrin-associated protein AP-3 complex |
Caenorhabditis elegans | CELE_R11A5.1 | Protein APB-3, isoform A |
Dictyostelium discoideum | DDB_G0274003 | beta adaptin |
Dictyostelium discoideum | DDB_G0272578 | beta adaptin |
Drosophila melanogaster | Dmel_CG11427 | ruby |
Echinococcus granulosus | EgrG_000341200 | AP 3 complex subunit beta 2 |
Entamoeba histolytica | EHI_083430 | Adapter-related protein complex 3 (AP-3) subunit, putative |
Echinococcus multilocularis | EmuJ_000341200 | AP 3 complex subunit beta 2 |
Homo sapiens | ENSG00000132842 | adaptor-related protein complex 3, beta 1 subunit |
Homo sapiens | ENSG00000103723 | adaptor-related protein complex 3, beta 2 subunit |
Leishmania braziliensis | LbrM.35.5510 | adaptin, putative |
Leishmania donovani | LdBPK_365490.1 | Adaptor protein complex AP-3 subunit beta-3 |
Leishmania infantum | LinJ.36.5490 | adaptin, putative |
Leishmania major | LmjF.36.5260 | adaptin, putative |
Leishmania mexicana | LmxM.36.5260 | adaptin, putative |
Loa Loa (eye worm) | LOAG_01807 | hypothetical protein |
Mus musculus | ENSMUSG00000021686 | adaptor-related protein complex 3, beta 1 subunit |
Mus musculus | ENSMUSG00000062444 | adaptor-related protein complex 3, beta 2 subunit |
Oryza sativa | 4326400 | Os01g0973300 |
Saccharomyces cerevisiae | YGR261C | Apl6p |
Schistosoma japonicum | Sjp_0072590 | IPR010733,Protein of unknown function DUF1308,domain-containing |
Schistosoma japonicum | Sjp_0082760 | AP-3 complex subunit beta-2, putative |
Schistosoma japonicum | Sjp_0108240 | AP-3 complex subunit beta-2, putative |
Schistosoma japonicum | Sjp_0038580 | hypothetical protein |
Schistosoma japonicum | Sjp_0110830 | expressed protein |
Schistosoma mansoni | Smp_140210 | adapter-related protein complex 3 beta subunit |
Schmidtea mediterranea | mk4.019515.00 | |
Schmidtea mediterranea | mk4.003511.03 | |
Schmidtea mediterranea | mk4.019515.01 | |
Trypanosoma brucei gambiense | Tbg972.11.11940 | beta-adaptin 3, putative,adaptin AP-3 complex beta3 subunit, putative |
Trypanosoma brucei | Tb927.11.10650 | Adaptor protein complex AP-3 subunit beta-3 |
Trypanosoma congolense | TcIL3000_0_26160 | Adaptor protein complex AP-3 subunit beta-3 |
Trypanosoma congolense | TcIL3000.11.11300 | Adaptor protein complex AP-3 subunit beta-3 |
Trypanosoma cruzi | TcCLB.506673.60 | Adaptor protein complex AP-3 subunit beta-3 |
Trypanosoma cruzi | TcCLB.504827.40 | Adaptor protein complex AP-3 subunit beta-3 |
Trichomonas vaginalis | TVAG_343480 | AP-3 complex subunit beta-1, putative |
Trichomonas vaginalis | TVAG_492750 | AP-3 complex subunit beta-1, putative |
Trichomonas vaginalis | TVAG_083310 | AP-3 complex subunit beta-1, putative |
Trichomonas vaginalis | TVAG_437420 | AP-3 complex subunit beta-1, putative |
Trichomonas vaginalis | TVAG_038150 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_050470 | AP-3 complex subunit beta-1, putative |
Trichomonas vaginalis | TVAG_390490 | AP-1 complex subunit beta-1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2420 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2420 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2420 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.2420 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_R11A5.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_R11A5.1 | Caenorhabditis elegans | larval arrest | wormbase |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.